HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 78 filers reported holding HARPOON THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 5.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $523,000 | -34.1% | 105,163 | 0.0% | 0.14% | -32.0% |
| Q4 2021 | $794,000 | -4.5% | 105,163 | 0.0% | 0.20% | -9.1% |
| Q3 2021 | $831,000 | -43.0% | 105,163 | 0.0% | 0.22% | -27.9% |
| Q2 2021 | $1,459,000 | -44.9% | 105,163 | -17.0% | 0.30% | -51.5% |
| Q1 2021 | $2,650,000 | +87.4% | 126,663 | +48.8% | 0.63% | +49.4% |
| Q4 2020 | $1,414,000 | -2.2% | 85,119 | 0.0% | 0.42% | -10.4% |
| Q3 2020 | $1,446,000 | +2.3% | 85,119 | 0.0% | 0.47% | +15.2% |
| Q2 2020 | $1,413,000 | -17.3% | 85,119 | -42.3% | 0.41% | -42.8% |
| Q1 2020 | $1,708,000 | – | 147,468 | – | 0.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $15,689,000 | 7.73% |
| MPM ASSET MANAGEMENT LLC | 3,131,388 | $15,563,000 | 5.32% |
| MPM BioImpact LLC | 3,196,707 | $15,888,000 | 4.26% |
| ACUTA CAPITAL PARTNERS, LLC | 497,500 | $2,473,000 | 1.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 151,445 | $2,771,000 | 0.62% |
| Orbimed Advisors | 3,039,508 | $15,106,000 | 0.24% |
| Artal Group S.A. | 1,000,000 | $4,970,000 | 0.21% |
| Cormorant Asset Management, LP | 540,600 | $2,687,000 | 0.21% |
| DAFNA Capital Management LLC | 105,163 | $523,000 | 0.14% |
| Ikarian Capital, LLC | 117,009 | $582,000 | 0.08% |